Pertussis, commonly known as whooping cough, has long been classified as a droplet-spread infection, meaning hospitals typically treat it with standard droplet precautions rather than the stricter airborne protocols reserved for diseases like measles or tuberculosis. But that classification is increasingly at odds with the laboratory evidence. A key animal study found that the pertussis bacterium, Bordetella pertussis, infected every single exposed animal even when direct physical contact was impossible, confirming transmission through aerosolized respiratory particles. The reality is messier than the neat droplet-versus-airborne categories suggest, and understanding the distinction matters for how you protect yourself and the people around you.
What the Droplet-Versus-Airborne Distinction Means in Practice
In infection control, “droplet” and “airborne” are not just descriptions of how a germ travels. They trigger entirely different sets of precautions. Droplet precautions assume the infectious particles are relatively large and heavy, falling to the ground within a meter or two of the source. That means a regular surgical mask, staying at arm’s length, and good hand hygiene are considered sufficient. Airborne precautions assume the particles are tiny enough to float in the air for extended periods and travel across a room or through ventilation systems. These precautions call for N95 respirators, negative-pressure isolation rooms, and restricted entry.
The traditional dividing line between the two categories has been a particle size of roughly five micrometers. Droplets larger than that are expected to settle quickly; particles smaller than that can remain suspended and drift. For decades, pertussis has been placed firmly in the “droplet” category in hospital guidelines. But as researchers have looked more carefully at what actually comes out of a cough, that five-micrometer boundary has started to feel arbitrary.
What a Cough Actually Produces
Coughing does not produce one uniform type of droplet. It generates a wide spray of particles across a huge range of sizes, from less than a micrometer up to several hundred micrometers. Research measuring cough aerosols in healthy volunteers found that droplets ranged from 0.1 to 900 micrometers, and particles smaller than one micrometer made up about 97% of the total count.
1PubMed Central. Cough aerosol in healthy participants: fundamental knowledge to optimize droplet-spread infectious respiratory disease managementA separate study measuring the droplets that remain suspended after a cough (the so-called droplet nuclei, which are the particles that do not settle quickly) found that about 82% of those nuclei fell in the range of roughly 0.7 to 2.1 micrometers, well below the traditional five-micrometer cutoff for airborne particles.
2PubMed. The size and concentration of droplets generated by coughing in human subjectsThis matters because pertussis is a disease defined by coughing, often violent, prolonged paroxysms. A person with active whooping cough may cough dozens of times in a single episode. Each of those coughs generates enormous numbers of tiny particles that can linger in the air long after the coughing stops. The sheer volume of sub-micrometer particles a pertussis patient produces makes the “droplet only” label seem optimistic.
The Baboon Experiments That Changed the Conversation
The strongest direct evidence that pertussis can spread through the air comes from a series of experiments using baboons, which are one of the few animals that develop pertussis in a way closely resembling the human disease. Researchers placed infected baboons in cages near uninfected animals, with barriers that prevented any physical contact or exchange of large droplets. The setup was designed so that only aerosolized particles, the kind that float through air, could pass between them.
The result was unambiguous: 100% of the uninfected baboons became colonized with B. pertussis, even though they never touched or came within close range of the infected animals.
3PubMed Central. Airborne transmission of Bordetella pertussis The researchers concluded that pertussis transmission occurs through aerosolized respiratory droplets, not just the large, quickly settling kind that the “droplet” classification implies.4PubMed. Airborne transmission of Bordetella pertussis demonstrated in a baboon model of whooping cough
These findings have not led to a wholesale reclassification of pertussis in hospital guidelines, which still generally call for droplet precautions rather than full airborne isolation. Part of the reason is practical: negative-pressure rooms are expensive and limited in number, and reserving them for every suspected pertussis case would strain hospital capacity. Part of it is that animal models do not always translate perfectly to human settings, where room ventilation, distances, and exposure patterns differ. But the baboon data remain hard to dismiss, and some infection-control specialists have argued that healthcare workers caring for pertussis patients should at minimum wear N95 respirators rather than simple surgical masks, particularly during procedures that provoke coughing.
How Contagious Pertussis Is
Regardless of whether you call it airborne or droplet, pertussis is extremely contagious. The basic reproduction number, which estimates how many people a single infected person would infect in a population with no immunity, sits between five and six for pertussis across multiple countries.
5PubMed Central. Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European Countries That puts it in the same general range as smallpox and well above influenza, which typically has a reproduction number around one to two. Measles, for comparison, is far higher at twelve to eighteen, but pertussis is still contagious enough that outbreaks can rip through unvaccinated or under-vaccinated communities with alarming speed.
In households, the risk is even more concentrated. When one family member has pertussis, close contacts who share living space are heavily exposed over days or weeks, especially because the most infectious period often begins before the characteristic whooping cough develops. Early symptoms look like an ordinary cold: runny nose, mild cough, low-grade fever. A parent or older sibling might cough for weeks without suspecting pertussis, all while shedding bacteria. A case investigation in the 1990s documented transmission from an adult in Massachusetts who visited the home of an infant in Michigan, illustrating how easily pertussis crosses long distances through casual household contact.
6PubMed. Transmission of pertussis from adult to infant–Michigan, 1993Why Vaccinated People Can Still Spread the Bacteria
One of the most significant findings in pertussis research over the past decade is that the acellular pertussis vaccines used in most high-income countries since the 1990s do a good job of preventing severe disease but do not reliably prevent infection or onward transmission. In the baboon model, animals vaccinated with acellular pertussis vaccine were protected from the worst symptoms of whooping cough but still became colonized with the bacteria, did not clear it any faster than completely unvaccinated animals, and readily transmitted it to unvaccinated contacts.
7PubMed Central. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate modelThe older whole-cell pertussis vaccines, which were phased out in many countries due to higher rates of side effects, appear to do a better job on this front. Research comparing the two vaccine types found that whole-cell vaccination could prevent transmission, while the acellular vaccine that effectively controlled disease failed to control shedding and transmission.
8PubMed Central. Different Effects of Whole-Cell and Acellular Vaccines on Bordetella TransmissionThis distinction has real consequences. It means that a fully vaccinated teenager or adult can be walking around with B. pertussis colonizing their respiratory tract, experiencing minimal or no symptoms, and still breathing out bacteria that could infect a vulnerable infant. Vaccination remains critical because it dramatically reduces the severity of illness and saves lives, but it does not create a reliable firewall against transmission the way measles vaccination does.
The Problem of Asymptomatic Carriers
The vaccine-and-transmission gap feeds into a broader problem: asymptomatic spread. Modeling work examining pertussis trends in the United States and United Kingdom found that the pattern of rising pertussis cases is consistent with widespread asymptomatic transmission. The analysis also revealed more genetic diversity in the circulating bacterial population than the number of reported symptomatic cases would predict, which is exactly what you’d expect if a large reservoir of undetected infections were silently keeping the bacteria in circulation.
9PubMed Central. Asymptomatic transmission and the resurgence of Bordetella pertussisThis has uncomfortable implications for one of the main strategies used to protect newborns: “cocooning,” which involves vaccinating everyone in close contact with an infant too young to be vaccinated, on the theory that surrounding the baby with immune people creates a protective barrier. The modeling suggests cocooning may be less effective than hoped, because the vaccinated adults in the cocoon can still carry and shed the bacteria without showing symptoms.
9PubMed Central. Asymptomatic transmission and the resurgence of Bordetella pertussisA key factor in this dynamic appears to be mucosal immunity, the immune defenses lining the nose and throat. Natural infection with pertussis tends to generate strong mucosal immunity that can block colonization entirely. Acellular vaccines, by contrast, are injected into muscle and primarily stimulate systemic immunity in the bloodstream, leaving the mucosal surfaces relatively unguarded. Researchers have argued that this gap in mucosal protection is a critical driver of the pertussis resurgence seen in many vaccinated populations.
10PubMed Central. The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussisWhat Antibiotics Can and Cannot Do for Exposed Contacts
When someone in a household or school is diagnosed with pertussis, public health authorities often recommend prophylactic antibiotics for close contacts, particularly those at high risk like infants or pregnant women in their final weeks. Macrolide antibiotics such as azithromycin are the standard choice. But the evidence for how well this works is thinner than you might expect. A Cochrane systematic review found that antibiotics given to contacts older than six months did not significantly improve clinical symptoms or reduce the number who went on to develop culture-positive B. pertussis infection. The review concluded there is insufficient evidence to determine the benefits of prophylactic treatment for pertussis contacts.
11PubMed Central. Antibiotics for whooping cough (pertussis)That does not mean prophylaxis is useless. It may help in specific circumstances, particularly for very young infants who face the highest risk of severe complications and death from pertussis. And antibiotics given to the infected person early in the illness can shorten the period during which they are contagious, even if they do not dramatically change the course of their symptoms. But the Cochrane findings are a reminder that once exposure has happened, there is no reliable pharmacological safety net. Prevention through vaccination and early isolation of suspected cases matters far more than post-exposure cleanup.
Practical Precautions That Actually Help
Given that pertussis bacteria travel in particles ranging from sub-micrometer aerosols to large visible droplets, a layered approach to prevention makes the most sense. In healthcare settings, the official recommendation is droplet precautions: a surgical mask within about a meter of the patient, plus contact precautions like gowns and gloves. But if you are a healthcare worker performing a procedure likely to trigger coughing, such as suctioning or taking a nasopharyngeal swab, wearing an N95 or equivalent respirator is a reasonable upgrade, given what the aerosol data show.
At home, the practical steps are less about personal protective equipment and more about timing. Pertussis is most contagious during the first two weeks of cough, before the distinctive whooping often develops. If you or your child has a persistent cough that does not improve after a week, especially if it comes in fits or is followed by vomiting, getting tested early gives you the best chance of starting antibiotics while they can still reduce the contagious window. Five days of appropriate antibiotic treatment is generally considered sufficient to make a patient non-contagious.
Ventilation helps too. Opening windows, running fans, and avoiding crowded poorly ventilated spaces are the same generic measures that reduce exposure to any respiratory pathogen, and they are relevant for pertussis precisely because a meaningful fraction of cough particles are small enough to accumulate in stagnant indoor air. These measures will not eliminate risk, but they reduce the concentration of airborne bacteria in a shared space.
Why the Classification Still Matters
The droplet-versus-airborne debate might seem like an academic turf war, but it has practical consequences at scale. When hospitals classify a pathogen as droplet-only, they allow patients to be housed in regular rooms with standard ventilation. Staff wear surgical masks that filter large particles but let smaller aerosols through. These measures work well for infections that genuinely spread only through large droplets, but they leave gaps for a pathogen like pertussis that clearly can hitch a ride on fine aerosols.
The COVID-19 pandemic forced a broader reckoning with the artificial neatness of the droplet-versus-airborne binary. Many respiratory pathogens, it turns out, spread through a continuum of particle sizes, and the hard cutoff at five micrometers was always more administrative convenience than biological reality. Pertussis fits squarely into this gray zone. The cough-aerosol research shows that the vast majority of coughed particles by number are small enough to remain airborne, even though the largest droplets carry the most total volume of fluid. Whether those tiny particles carry enough bacteria to cause infection in real-world human settings, outside of a controlled baboon experiment, remains an open question.
For you as an individual, the practical upshot is simple: treat pertussis as potentially airborne when it matters most. If there is a case in your household and you have an unvaccinated infant, brief casual contact is not the only risk. Sharing indoor air with a coughing family member can be enough. Ventilation, early treatment, and keeping vulnerable people physically separated from symptomatic individuals during the contagious period are all worth taking seriously, even if the official guidelines have not fully caught up with the aerosol science.
Adults and the Underreporting Problem
Pertussis in adults tends to fly under the radar. The classic whooping cough presentation, with its dramatic inspiratory whoop and cyanotic spells, is most common in unvaccinated young children. Adults who were vaccinated years ago and whose immunity has waned typically get a persistent, annoying cough that they attribute to a cold, allergies, or bronchitis. Reporting data from the early 1990s showed that only about 10% of pertussis cases were reported at all, and underreporting was even greater among adults.
6PubMed. Transmission of pertussis from adult to infant–Michigan, 1993This underreporting feeds the transmission cycle. An adult with a “persistent cough” who never gets tested continues going to work, visiting family, and breathing on everyone around them for weeks. They are unlikely to seek treatment early enough for antibiotics to shorten their contagious period. And because acellular vaccine immunity wanes substantially within five to ten years of the last dose, the pool of susceptible adults is enormous. Booster vaccination with Tdap is recommended for all adults, particularly those in contact with infants, but uptake remains patchy in most countries. Every undiagnosed adult case is a potential bridge to an infant who cannot yet be vaccinated and for whom pertussis can be fatal.